Stephen Morris
Pulmonary Disease · Savannah, GANPI 1538104567
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,976 and has fallen 97.4% since, to $51 in 2023. That places this record below the midpoint for pulmonary disease clinicians in GA, where the typical reported total is $3,789.
Across 258 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$655
- AstraZeneca$619
- Boehringer Ingelheim$604
- Jazz Pharmaceuticals Inc.$315
- Grifols USA, LLC$265
- Philips North America LLC$263
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,56799%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 46 | $655 |
| AstraZeneca | 29 | $619 |
| Boehringer Ingelheim | 29 | $604 |
| Jazz Pharmaceuticals Inc. | 17 | $315 |
| Grifols USA, LLC | 10 | $265 |
| Philips North America LLC | 17 | $263 |
| Insmed, Inc. | 18 | $254 |
| Regeneron Healthcare Solutions, Inc. | 9 | $238 |
| Sanofi | 8 | $154 |
| Mallinckrodt Hospital Products Inc. | 6 | $130 |
| AbbVie(2 entities) | 6 | $91 |
| Arbor Pharmaceuticals, Inc. | 5 | $81 |
| United Therapeutics Corporation | 5 | $81 |
| Genentech USA, Inc. | 4 | $68 |
| Mylan Specialty L.p. | 3 | $64 |
| Actelion Pharmaceuticals US, Inc. | 4 | $63 |
| Merck | 5 | $59 |
| Harmony Biosciences LLC | 4 | $57 |
| Shire North American Group Inc | 3 | $51 |
| Sunovion Pharmaceuticals Inc. | 4 | $51 |
| Circassia Inc. | 3 | $50 |
| Mallinckrodt Enterprises LLC | 4 | $48 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $46 |
| Advanced Respiratory, Inc | 2 | $40 |
| Johnson & Johnson | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| ADMA Biomanufacturing LLC | 1 | $23 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $17 |
| Biogen | 1 | $16 |
| Fisher & Paykel Healthcare Inc | 1 | $15 |
| CSL Behring | 1 | $15 |
| Apria Healthcare LLC | 1 | $14 |
| Electromed, Inc. | 1 | $14 |
| Smith+Nephew | 1 | $11 |
| Ambu Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$103
How this compares
$4,608 in reported general payments places this provider in the 50th percentile of 365 pulmonary disease providers in Georgia.
Other pulmonary disease in Savannah
- Lawrence McDermottSavannah$963K
- Michael MullinsSavannah$132K
- Michael PerkinsSavannah$67K
- Ryan MoodySavannah$50K
- Gifford LorenzSavannah$20K
- Vivek SambharaGainesville$417K
- Chad MillerAustell$382K
- Nehal BhattAthens$371K
- Maria MascoloRincon$358K
- Colin SwensonAtlanta$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.